News & Commentary

Setting the Record Straight on Drug Discounts

We recently celebrated the 25th anniversary of the 340B Drug Pricing Program, signed into law by then-President George H.W. Bush. With strong bipartisan support, the law requires drug companies to discount their prices when they sell to clinics, … [Read more...]

No, Health Costs Aren’t Rising Because of Drug Discount Programs

Why would a group that claims to hate government waste want to tear down a small federal health-care program that saves taxpayers money? We should first start by following the money. In The Hill, the group Citizens Against Government Waste tore … [Read more...]

This Drug Discount Program is Good for Americans. But PHARMA Wants to Gut it

Sticker shock over the cost of drugs isn’t going away any time soon. Drug prices spiked 7 percent last year, the highest rate since 1992. Compare that with the modest increase of just 0.8 percent in hospital care costs. So why is the … [Read more...]

340B: A Program Worth Fighting For

The federal 340B drug discount program is essential to helping safety net providers meet their missions to treat the underserved. The program is under heavy attack in Washington, DC by the drug industry, which wants to gut it to maximise profits. At … [Read more...]

Three Proposals That Would Kill the 340B Program

In the December issue of Evidence-Based Oncology, Rena M. Conti, PhD; Peter B. Bach, MD, MAPP; and Michael Kolodziej, MD, laid out 3 proposals to reform the 340B Drug Discount Program. However, their prescriptions would effectively cause the … [Read more...]

Setting the Record Straight on Drug Shortages

John Goodman of the National Center for Policy Analysis (NCPA) says in a June 8 Health Affairs Blog entry that the Public Health Service 340B drug discount program is part of a "web of [federal] regulations that are preventing life saving drugs from … [Read more...]